These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9351772)

  • 41. Cost effectiveness of a test to detect metastases for endometrial cancer.
    Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
    Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
    van Baaren GJ; Vis JY; Grobman WA; Bossuyt PM; Opmeer BC; Mol BW
    Am J Obstet Gynecol; 2013 Nov; 209(5):436.e1-8. PubMed ID: 23791688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An economic evaluation of alternative test-intervention strategies to prevent spontaneous pre-term birth in singleton pregnancies.
    Tsourapas A; Roberts TE; Barton PM; Honest H; Forbes C; Hyde CJ; Khan KS
    Acta Obstet Gynecol Scand; 2009; 88(12):1319-30. PubMed ID: 19943821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determining a cutoff for fetal lung maturity with lamellar body count testing.
    Janicki MB; Dries LM; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 May; 22(5):419-22. PubMed ID: 19529999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
    Doyle NM; Levison JE; Gardner MO
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amniotic fluid lamellar body count and its sensitivity and specificity in evaluating of fetal lung maturity.
    Khazardoost S; Yahyazadeh H; Borna S; Sohrabvand F; Yahyazadeh N; Amini E
    J Obstet Gynaecol; 2005 Apr; 25(3):257-9. PubMed ID: 16147729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antenatal steroid therapy: have we undervalued the risks?
    Cavalieri RL; Cohen WR
    J Matern Fetal Neonatal Med; 2006 May; 19(5):265-9. PubMed ID: 16753765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The biophysical/biochemical test. A new marker of fetal lung maturity in borderline cases.
    Piazze JJ; Anceschi MM; Maranghi L; Porpora MG; Cosmi EV
    J Reprod Med; 1999 Jul; 44(7):611-5. PubMed ID: 10442324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Practice guideline 'Perinatal management of extremely preterm delivery'].
    de Laat MW; Wiegerinck MM; Walther FJ; Boluyt N; Mol BW; van der Post JA; van Lith JM; Offringa M; ;
    Ned Tijdschr Geneeskd; 2010; 154():A2701. PubMed ID: 21429260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple vs. single betamethasone therapy. Neonatal and maternal effects.
    Pratt L; Waschbusch L; Ladd W; Gangnon R; Hendricks SK
    J Reprod Med; 1999 Mar; 44(3):257-64. PubMed ID: 10202744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreasing frequency of iatrogenic neonatal respiratory distress syndrome.
    Berkowitz GS; Chang K; Chervenak FA; Krouskop R; Wilkins IA
    Am J Perinatol; 1986 Jul; 3(3):205-8. PubMed ID: 3521636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prenatal lung maturation with corticosteroids--an overview].
    Hildebrand K; Hösli I; Holzgreve W
    Z Geburtshilfe Neonatol; 1996; 200(6):207-12. PubMed ID: 9081746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acceleration of fetal pulmonary maturity.
    Bishop EH
    Obstet Gynecol; 1981 Nov; 58(5 Suppl):48S-51S. PubMed ID: 7312228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tocolysis with hexoprenaline in premature rupture of fetal membranes. Effectiveness and treatment costs].
    Spitzer D; Zajc M; Heiss O; Steiner H; Staudach A
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():145-6. PubMed ID: 8118246
    [No Abstract]   [Full Text] [Related]  

  • 55. [Tocolysis in imminent premature delivery: limits of indication--assessment of success--sources of error (author's transl)].
    Staudach A
    Z Geburtshilfe Perinatol; 1981 Apr; 185(2):84-8. PubMed ID: 7196122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preterm delivery from 34 to 37 weeks of gestation: is respiratory distress syndrome a problem?
    Lewis DF; Futayyeh S; Towers CV; Asrat T; Edwards MS; Brooks GG
    Am J Obstet Gynecol; 1996 Feb; 174(2):525-8. PubMed ID: 8623778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature].
    Gandibleux-Bergiers MF
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome. Beneficial and adverse effects.
    Kimya Y; Küçükkömürcü S; Ozan H; Uncu G
    Clin Exp Obstet Gynecol; 1995; 22(3):204-11. PubMed ID: 7554258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic induction of fetal lung maturity.
    Roberts WE; Morrison JC
    Clin Obstet Gynecol; 1991 Jun; 34(2):319-27. PubMed ID: 1868639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Problems in inducing pulmonary maturation in relation to premature delivery].
    Mĕchurová A
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():50-4. PubMed ID: 11394234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.